Relationships Between the Na(+)/K(+) Pump and ATP and ADP Content in Mouse Pancreatic Islets: Effects of Meglitinide and Glibenclamide

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2001 Jan 5

PMID 11139449

Citations 4

Authors

A Elmi

L A Idahl

J Sehlin

Affiliations

Soon will be listed here.

Abstract

We have previously demonstrated that both D-glucose and glibenclamide stimulate the Na(+)/K(+) pump and suggested that this may be part of the membrane repolarization process, following the primary depolarization by these agents. The aim of this study was to investigate whether the non-sulphonylurea meglitinide (HB 699) exerts similar effects as glibenclamide or glucose on the islet Na(+)/K(+) pump and if effects of meglitinide or glibenclamide on this pump activity is paralleled by changes in islet ATP content and/or ATP/ADP ratio. The acyl-amino-alkyl benzoic acid derivative, meglitinide, stimulated the islet ouabain-sensitive portion of (86)Rb(+) influx (Na(+)/K(+) pump) by 53%, while the ouabain-resistant portion was inhibited by 70%. The stimulatory effect was not additive to that caused by D-glucose, suggesting that both agents may activate the Na(+)/K(+) pump via the same mechanism. Glibenclamide (10 microM) decreased the islet ATP and ADP content as well as the ATP/ADP ratio at 0 mM glucose. These effects were no longer observed at 10 mM glucose. Meglitinide (10 or 50 microM) lowered the islet ATP and ADP content at 0 mM glucose without affecting the ATP/ADP ratio. At 10 mM glucose, however, 10 microM of the drug reduced the islet ATP content but not the ATP/ADP ratio, while 50 microM of the drug, besides lowering the ATP content, also reduced the ATP/ADP ratio. Diazoxide (0.5 mM) increased the islet ATP content in the absence of glucose, an effect not seen in the presence of 10 mM glucose. The rate of glucose oxidation at 1, 10 or 20 mM of the sugar was not affected by glibenclamide (0.1 - 10 microM) and at 10 or 20 mM of the sugar not affected by meglitinide (1 - 100 microM). These results suggest that glibenclamide and meglitinide lower the islet ATP level by indirectly activating the beta-cell Na(+)/K(+) pump, which is a major consumer of ATP in the islets, while diazoxide increases the ATP level due to inhibition of the pump.

Citing Articles

Interaction of Aqueous Extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with Glyburide in Alloxan Induced Diabetic Mice.

Badole S, Patel N, Thakurdesai P, Bodhankar S Evid Based Complement Alternat Med. 2008; 5(2):159-64.

PMID: 18604261 PMC: 2396481. DOI: 10.1093/ecam/nem010.

Fuel-induced amplification of insulin secretion in mouse pancreatic islets exposed to a high sulfonylurea concentration: role of the NADPH/NADP+ ratio.

Panten U, Rustenbeck I Diabetologia. 2007; 51(1):101-9.

PMID: 17960358 DOI: 10.1007/s00125-007-0849-z.

Selective loss of glucose-induced amplification of insulin secretion in mouse pancreatic islets pretreated with sulfonylurea in the absence of fuels.

Urban K, Panten U Diabetologia. 2005; 48(12):2563-6.

PMID: 16283243 DOI: 10.1007/s00125-005-0030-5.

Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells.

Sautin Y, Lu M, Gaugler A, Zhang L, Gluck S Mol Cell Biol. 2005; 25(2):575-89.

PMID: 15632060 PMC: 543406. DOI: 10.1128/MCB.25.2.575-589.2005.

References

Borg L, Andersson A . Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations. Acta Diabetol Lat. 1981; 18(1):65-83. DOI: 10.1007/BF02056108. View

Elmi A, Idahl L, Sehlin J . Modulation of beta-cell ouabain-sensitive 86Rb+ influx (Na+/K+ pump) by D-glucose, glibenclamide or diazoxide. Int J Exp Diabetes Res. 2001; 1(4):265-74. PMC: 2477744. DOI: 10.1155/edr.2000.265. View

Efendic S, Enzmann F, Gutniak M, Nylen A, Zoltobrocki M . Insulin, glucagon and somatostatin in the perfused rat pancreas and the effects of HB 699 (4-(2-(5-chloro-2-metoxy-benzamido)-ethyl)-benzoic acid). Acta Endocrinol (Copenh). 1981; 98(4):573-9. DOI: 10.1530/acta.0.0980573. View

Henquin J, MEISSNER H . Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells. Biochem Pharmacol. 1982; 31(7):1407-15. DOI: 10.1016/0006-2952(82)90036-3. View

Henquin J, MEISSNER H . The electrogenic sodium-potassium pump of mouse pancreatic B-cells. J Physiol. 1982; 332:529-52. PMC: 1197414. DOI: 10.1113/jphysiol.1982.sp014429. View

Lindstrom P, Sehlin J . Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase. Endocrinology. 1983; 112(4):1524-9. DOI: 10.1210/endo-112-4-1524. View

Welsh M . The effects of glibenclamide on rat islet radioactive nucleotide efflux, ATP contents and respiratory rates. Biochem Pharmacol. 1983; 32(19):2903-8. DOI: 10.1016/0006-2952(83)90394-5. View

Brown G, Foubister A . Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids. J Med Chem. 1984; 27(1):79-81. DOI: 10.1021/jm00367a016. View

Norlund L, Sehlin J . The acyl-amino-alkyl benzoic acid residue and the sulfonylurea containing residue of glibenclamide affect different aspects of beta-cell function. Acta Physiol Scand. 1984; 120(2):283-6. DOI: 10.1111/j.1748-1716.1984.tb00135.x. View

10.

Gylfe E, Hellman B, Sehlin J, Taljedal B . Interaction of sulfonylurea with the pancreatic B-cell. Experientia. 1984; 40(10):1126-34. DOI: 10.1007/BF01971460. View

11.

Sturgess N, Ashford M, Cook D, Hales C . The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet. 1985; 2(8453):474-5. DOI: 10.1016/s0140-6736(85)90403-9. View

12.

Garrino M, Schmeer W, Nenquin M, MEISSNER H, Henquin J . Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia. 1985; 28(9):697-703. DOI: 10.1007/BF00291979. View

13.

Trube G, Rorsman P . Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Arch. 1986; 407(5):493-9. DOI: 10.1007/BF00657506. View

14.

Dunne M, Illot M, Peterson O . Interaction of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line. J Membr Biol. 1987; 99(3):215-24. DOI: 10.1007/BF01995702. View

15.

Zunkler B, Lenzen S, Manner K, Panten U, Trube G . Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells. Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(2):225-30. DOI: 10.1007/BF00169252. View

16.

Sandstrom P, Sehlin J . Furosemide-induced glucose intolerance in mice is associated with reduced insulin secretion. Eur J Pharmacol. 1988; 147(3):403-9. DOI: 10.1016/0014-2999(88)90175-6. View

17.

Ashcroft F, Rorsman P . Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol. 1989; 54(2):87-143. DOI: 10.1016/0079-6107(89)90013-8. View

18.

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505):425-32. DOI: 10.1038/372425a0. View

19.

Garcia-Barrado M, Jonas J, Gilon P, Henquin J . Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells. Eur J Pharmacol. 1996; 298(3):279-86. DOI: 10.1016/0014-2999(95)00806-3. View

20.

Detimary P, Jonas J, Henquin J . Stable and diffusible pools of nucleotides in pancreatic islet cells. Endocrinology. 1996; 137(11):4671-6. DOI: 10.1210/endo.137.11.8895332. View